Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Chitra Lal & Charlie Strange. (2019) Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD). Expert Opinion on Pharmacotherapy 20:9, pages 1075-1085.
Read now
Read now
Yoshiaki Minakata, Takashi Motegi, Jun Ueki, Yasuhiro Gon, Shuhei Nakamura, Tatsuhiko Anzai, Kazuto Hirata & Masakazu Ichinose. (2019) Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO® study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1789-1801.
Read now
Read now
Jill Ohar, Robert Tosiello, Thomas Goodin & Shahin Sanjar. (2019) Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 27-37.
Read now
Read now
Paola Rogliani, Luigino Calzetta, Maria Gabriella Matera, Nicola di Daniele, Andrea Girolami, Mario Cazzola & Josuel Ora. (2019) Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 20:6, pages 737-750.
Read now
Read now
Paola Rogliani, Josuel Ora, Maria Gabriella Matera, Mario Cazzola & Luigino Calzetta. (2018) The safety of dual bronchodilation on cardiovascular serious adverse events in COPD. Expert Opinion on Drug Safety 17:6, pages 589-596.
Read now
Read now
Craig LaForce, Eric Derom, Ulrich Bothner, Isabel M Kloer, Matthias Trampisch & Roland Buhl. (2018) Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1819-1831.
Read now
Read now
Articles from other publishers (9)
Marc Spielmanns, Sebastian Schildge, Jens Peter Diedrich & Arschang Valipour. (2022) Therapeutic Success in Swiss COPD Patients Receiving Dual Bronchodilation Therapy as COPD Maintenance Treatment. Clinics and Practice 12:1, pages 46-56.
Crossref
Crossref
Gary T. Ferguson, François Maltais, Jill Karpel, Ulrich Bothner, Isabel Kloer, Matthias Trampisch & Roland Buhl. (2020) Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies. npj Primary Care Respiratory Medicine 30:1.
Crossref
Crossref
Roland Buhl, Dave Singh, Alberto de la Hoz, Wenqiong Xue & Gary T. Ferguson. (2020) Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO® and OTEMTO® Studies. Advances in Therapy 37:8, pages 3485-3499.
Crossref
Crossref
Hannah A. Blair. (2019) Tiotropium/Olodaterol: A Review in COPD. Drugs 79:9, pages 997-1008.
Crossref
Crossref
Usman Maqsood, Terence N Ho, Karen Palmer, Fiona JR Eccles, Mohammed Munavvar, Ran Wang, Iain Crossingham & David JW Evans. (2019) Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019:3.
Crossref
Crossref
Antonio R. Anzueto, Konstantinos Kostikas, Karen Mezzi, Steven Shen, Michael Larbig, Francesco Patalano, Robert Fogel, Donald Banerji & Jadwiga A. Wedzicha. (2018) Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study. Respiratory Research 19:1.
Crossref
Crossref
Bartolome R. Celli. (2018) Pharmacological Therapy of COPD. Chest 154:6, pages 1404-1415.
Crossref
Crossref
Gary T. Ferguson, Roland Buhl, Ulrich Bothner, Alberto de la Hoz, Florian Voß, Antonio Anzueto & Peter M.A. Calverley. (2018) Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials. Respiratory Medicine 143, pages 67-73.
Crossref
Crossref
David M. G. Halpin. (2018) The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease. Tuberculosis and Respiratory Diseases 81:1, pages 13.
Crossref
Crossref